{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:22Z","timestamp":1787236462589,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H05744"],"award-info":[{"award-number":["20H05744"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17129"],"award-info":[{"award-number":["20K17129"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08164"],"award-info":[{"award-number":["22K08164"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cardfail.2022.10.433","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T02:51:59Z","timestamp":1681267919000},"page":"503-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review"],"prefix":"10.1016","volume":"29","author":[{"given":"YOSHIKAZU","family":"KISHINO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUGO","family":"TOHYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUIKA","family":"MORITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUSUKE","family":"SOMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDENORI","family":"TANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARINA","family":"OKADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEAKI","family":"KANAZAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEIICHI","family":"FUKUDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.10.433_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0002","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0004","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0006","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0007","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0008","doi-asserted-by":"crossref","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0009","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0010","first-page":"235","article-title":"The Registry Report of Japanese Heart Transplantation-2021","volume":"56","year":"2021","journal-title":"Ishoku"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0011","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1253\/circj.72.489","article-title":"Impending epidemic: future projection of heart failure in Japan to the year 2055","volume":"72","author":"Okura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0012","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0013","first-page":"261","article-title":"The Registry Report of Japanese Heart Transplantation-2020","volume":"55","year":"2020","journal-title":"Ishoku"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0014","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1253\/circj.CJ-21-0462","article-title":"Consensus Report on Destination Therapy in Japan: from the DT Committee of the Council for Clinical Use of Ventricular Assist Device-Related Academic Societies","volume":"85","author":"Kinugawa","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MAT.0000000000000916","article-title":"Obesity is associated with driveline infection of left ventricular assist devices","volume":"65","author":"Akay","year":"2019","journal-title":"Asaio J"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0016","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jchf.2016.05.010","article-title":"The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices","volume":"4","author":"Clerkin","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0017","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/j.jtcvs.2019.09.080","article-title":"Increasing the United States heart transplant donor pool with donation after circulatory death","volume":"159","author":"Jawitz","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0018","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.healun.2022.06.016","article-title":"The future of heart procurement with donation after circulatory death: current practice and opportunities for advancement","volume":"41","author":"Ayer","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0019","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.304510","article-title":"MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function","volume":"116","author":"Jayawardena","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2021.11.008","article-title":"Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy","volume":"164","author":"Tani","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.774389","article-title":"The present state and future perspectives of cardiac regenerative therapy using human pluripotent stem cells","volume":"8","author":"Soma","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-019-0110-4","article-title":"Toward the realization of cardiac regenerative medicine using pluripotent stem cells","volume":"40","author":"Kishino","year":"2020","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0024","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/14779072.6.6.803","article-title":"Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era","volume":"6","author":"Yuasa","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0026","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0027","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cardfail.2015.04.010","article-title":"Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies","volume":"21","author":"Kamdar","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0028","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0029","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/stem.3027","article-title":"Concise review: genetic and epigenetic regulation of cardiac differentiation from human pluripotent stem cells","volume":"37","author":"Fujita","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.RES.67.1.23","article-title":"Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats","volume":"67","author":"Olivetti","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0031","first-page":"I141","article-title":"The relationship of myocardial infarct size and prognosis","volume":"53","author":"Caulfield","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2015.11.016","article-title":"Large-scale production of human pluripotent stem cell derived cardiomyocytes","volume":"96","author":"Kempf","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0033","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.5966\/sctm.2014-0072","article-title":"A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Hemmi","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0034","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","article-title":"Efficient large-scale 2D culture system for human-induced pluripotent stem cells and differentiated cardiomyocytes","volume":"9","author":"Tohyama","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat Meth"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0036","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101341","article-title":"Protocol for enhanced proliferation of human pluripotent stem cells in tryptophan-fortified media","volume":"3","author":"Kameda","year":"2022","journal-title":"STAR Protoc"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102090","article-title":"Tryptophan metabolism regulates proliferative capacity of human pluripotent stem cells","volume":"24","author":"Someya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.chembiol.2017.04.010","article-title":"Efficient, selective removal of human pluripotent stem cells via ecto-alkaline phosphatase-mediated aggregation of synthetic peptides","volume":"24","author":"Kuang","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0040","doi-asserted-by":"crossref","first-page":"32532","DOI":"10.1038\/srep32532","article-title":"MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells","volume":"6","author":"Parr","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0041","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.stemcr.2015.02.016","article-title":"Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein","volume":"4","author":"Tateno","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0042","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nbt.1947","article-title":"An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells","volume":"29","author":"Tang","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0043","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12015-009-9054-4","article-title":"Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS)","volume":"5","author":"Fong","year":"2009","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0044","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nbt.2005","article-title":"SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells","volume":"29","author":"Dubois","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2019.02.094","article-title":"Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3","volume":"511","author":"Okada","year":"2019","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0047","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cmet.2016.03.001","article-title":"Glutamine oxidation is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tohyama","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101535","article-title":"Fatty acid synthesis is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tanosaki","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0049","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41232-021-00156-9","article-title":"Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes","volume":"41","author":"Tanosaki","year":"2021","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nbt.2005","article-title":"SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells","volume":"29","author":"Dubois","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0051","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12015-009-9054-4","article-title":"Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS)","volume":"5","author":"Fong","year":"2009","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0052","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/eurheartj\/ehs096","article-title":"Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients","volume":"34","author":"Zwi-Dantsis","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0053","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0054","doi-asserted-by":"crossref","first-page":"H1169","DOI":"10.1152\/ajpheart.00376.2012","article-title":"Myocardial cell sheet therapy and cardiac function","volume":"303","author":"Fujita","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0055","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCRESAHA.108.186742","article-title":"IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha\/CXCR4 signaling to promote myocardial repair","volume":"103","author":"Haider","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0056","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","article-title":"Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement","volume":"20","author":"Gnecchi","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0057","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0058","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.109.197723","article-title":"Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression","volume":"104","author":"Tang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0059","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","article-title":"Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction","volume":"117","author":"Khan","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cardiores.2004.10.004","article-title":"Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice","volume":"65","author":"Hattan","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0061","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cellderived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0062","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.1403","article-title":"Nongenetic method for purifying stem cell-derived cardiomyocytes","volume":"7","author":"Hattori","year":"2010","journal-title":"Nat Meth"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0063","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0064","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0065","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0066","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0067","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacbts.2020.11.017","article-title":"Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0068","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2016.10.009","article-title":"In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts","volume":"8","author":"Kadota","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0069","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","article-title":"Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine","volume":"17","author":"Karbassi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0071","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stem cell therapy","volume":"577","author":"Vagnozzi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0072","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0073","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cardiores.2005.03.014","article-title":"Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets","volume":"67","author":"Itabashi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0074","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2012.01.023","article-title":"Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model","volume":"53","author":"Thompson","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0075","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0076","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0077","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","article-title":"HLA engineering of human pluripotent stem cells","volume":"21","author":"Riolobos","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0078","doi-asserted-by":"crossref","DOI":"10.1086\/302519","article-title":"The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes","volume":"65","author":"DeSandro","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0079","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted disruption of the beta2-microglobulin gene minimizes the immunogenicity of human embryonic stem cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0081","doi-asserted-by":"crossref","first-page":"10441","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0082","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0083","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0084","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human-induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1749-8090-7-117","article-title":"The effectiveness of rigid pericardial endoscopy for minimally invasive minor surgeries: cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation","volume":"7","author":"Kimura","year":"2012","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0086","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/stem.1089","article-title":"Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization","volume":"30","author":"Masumoto","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0087","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/TP.0000000000002765","article-title":"MHC-mismatched allotransplantation of induced pluripotent stem cell-derived cardiomyocyte sheets to improve cardiac function in a primate ischemic cardiomyopathy model","volume":"103","author":"Kashiyama","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0088","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2009.07.024","article-title":"Omentopexy enhances graft function in myocardial cell sheet transplantation","volume":"387","author":"Suzuki","year":"2009","journal-title":"Biochem Biophys Res Communicat"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0089","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2022.10.433_bib0090","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/ncomms3307","article-title":"Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells","volume":"4","author":"Lu","year":"2013","journal-title":"Nat Commun"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:47Z","timestamp":1761029387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1071916423000374"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.10.433","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.10.433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}